Case report · 15 Aug 2020
Short communicationPublished 2016
Combination Therapy for Chronic Lymphoid Leukemia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
For decades, the treatment of chronic lymphocytic leukemia (CLL) has relied on cytotoxic drugs with incremental benefit from anti-CD20 monoclonal antibodies. However, in the past 5 years, targeted drugs have fundamentally changed the management and outcome of CLL
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Case report · 2019
Lineage Switch from Acute Lymphoid Leukemia to Acute Myeloid Leukemia
Conference abstract · 7 Jul 2025
EZH2 inhibition as a potential therapy for patients with chronic lymphocytic leukemia patients
Conference abstract · 7 May 2018
Cancer Therapy 2018: An unexpected case of B-cell chronic lymphocytic leukemia (CLL) and aggressive metastatic colonic adenocarcinoma - Vincenzo Russo - University-Hospital San Martino
Research article · 2015
Phytohemagglutinin-Induced Peripheral Blood Cytogenetics: A Valid Means for Diagnosis and Imatinib Therapy Monitoring of Chronic Phase Chronic Myeloid Leukemia Patients
More from this journal
The newest in Cancer Science & Therapy.
Commentary · 21 Feb 2026
Functional Immune Biomarker Identification in Patients with Breast Cancer
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Satadal Barik”

